首页> Health science reports> Evaluation of SARS-CoV-2 Variants After the Declaration of End of COVID-19 Pandemic: BA.2.86 (Pirola) and EG.5 (Eris) Variants as Global Public Health Concerns.

Evaluation of SARS-CoV-2 Variants After the Declaration of End of COVID-19 Pandemic: BA.2.86 (Pirola) and EG.5 (Eris) Variants as Global Public Health Concerns.

导出 LinkOut

翻译打印收藏纠错

第一作者： Md Rabiul,Islam

第一单位： School of Pharmacy BRAC University Dhaka Bangladesh.

作者： Md Rabiul,Islam ^[1] ; Md,Sohan ^[2] ; A S M,Roknuzzaman ^[2] ; Mehedi,Islam ^[1] ; Mohammad,Shahriar ^[2] ; Mohiuddin Ahmed,Bhuiyan ^[2]

作者单位： School of Pharmacy BRAC University Dhaka Bangladesh. ^[1] Department of Pharmacy University of Asia Pacific Dhaka Bangladesh. ^[2]

关键词 BA.2.86 COVID‐19 EG.5 SARS‐CoV‐2 variants communicable disease public health

DOI 10.1002/hsr2.71394

PMID 41132189

发布时间 2025-10-27

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Health science reports

2025年8卷10期

e71394页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Health science reports

2025年8卷10期

e71394页

检索历史清除

Evaluation of SARS-CoV-2 Variants After the Declaration of End of COVID-19 Pandemic: BA.2.86 (Pirola) and EG.5 (Eris) Variants as Global Public Health Concerns.

Health science reports

相似文献

同项目论文

Health science reports

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Evaluation of SARS-CoV-2 Variants After the Declaration of End of COVID-19 Pandemic: BA.2.86 (Pirola) and EG.5 (Eris) Variants as Global Public Health Concerns.

Health science reports

相似文献

同项目论文

Health science reports

相关期刊

检索历史清除